HESI Pharmacology IV Exam

Correct answer A: Consumption of any alcohol or tyramine-rich foods.

Explanation of the correct answer:

A. Consumption of any alcohol or tyramine-rich foods.

Phenelzine (Nardil) is a monoamine oxidase inhibitor (MAOI) used to treat depression. MAOIs can interact with certain foods that contain tyramine, a naturally occurring compound found in aged cheeses, cured meats, fermented foods, and certain alcoholic beverages (such as red wine and beer). Consuming these foods while on an MAOI can cause a hypertensive crisis, which is a life-threatening increase in blood pressure. Therefore, it is critical for the nurse to assess the client’s dietary habits and provide education on avoiding tyramine-rich foods and certain alcoholic beverages while taking phenelzine. This is the most important safety consideration.

Why the other options are incorrect:

B. Reports of nausea or vomiting.

While nausea or vomiting could be side effects of phenelzine, they are not as immediately dangerous as the risk of hypertensive crisis caused by tyramine interactions. While it is important to monitor for side effects, this is not the most important assessment compared to dietary restrictions.

C. Therapeutic serum drug levels.

MAOIs like phenelzine do not require routine monitoring of serum drug levels, unlike some other medications (such as lithium or phenytoin). The primary concern with phenelzine is its interaction with certain foods and other medications, not its serum concentration.

D. Blood pressure and pulse prior to taking each dose.

Although it is important to monitor blood pressure due to the potential for hypertensive crisis, the most critical aspect to assess in relation to phenelzine is the client’s dietary intake of tyramine. Monitoring blood pressure regularly is important, but dietary restrictions take precedence to prevent dangerous interactions.

Summary:

When administering phenelzine (Nardil), the nurse’s most important action is to assess the client’s consumption of alcohol or tyramine-rich foods, as consuming these can trigger a hypertensive crisis, a serious and potentially fatal reaction.

The correct answer is B: Administer the initial dose of the aminoglycoside antibiotic as soon as possible.

Detailed Explanation:

In this scenario, the healthcare provider has prescribed an IV aminoglycoside antibiotic based on the results of blood culture and sensitivity and has also discontinued the broad-spectrum antibiotic. The client has already received the broad-spectrum antibiotic two hours ago, and now the nurse is determining the correct course of action to start the new aminoglycoside therapy.

Here’s why B is the best choice:

Aminoglycosides and Timing: Aminoglycosides (such as gentamicin, tobramycin, or amikacin) are typically dosed based on the pharmacokinetics of the drug. These antibiotics are generally administered in a single dose or once-daily dosing in many cases (depending on the infection and the patient's condition). In these regimens, the focus is on achieving high peak levels and allowing the drug to be cleared from the body before the next dose. This allows the kidneys time to process the drug and reduces the risk of toxicity.

Overlap of Broad-Spectrum Antibiotic: The fact that the client received the broad-spectrum antibiotic two hours ago is important. However, many broad-spectrum antibiotics and aminoglycosides can be safely administered in parallel, especially if the client has an acute infection requiring immediate intervention. The nurse should be guided by the healthcare provider’s order to administer the aminoglycoside as soon as possible, which is likely to be the correct course of action if the infection is severe.

No Delay in Treatment: In situations where there is an urgent need for treatment (e.g., severe bacterial infections), it’s important not to delay the start of the aminoglycoside. This ensures the infection is controlled while waiting for the correct sensitivity results or confirmation of which antibiotic is most effective. The nurse should proceed with the aminoglycoside as soon as possible unless contraindications or potential drug interactions are specifically identified.

Why the Other Options Are Incorrect:

A. Obtain peak and trough serum levels so the aminoglycoside antibiotic can be initiated:

Peak and trough levels are important for aminoglycosides, but these levels are usually monitored after the initial dose is given and at specific times (e.g., peak level 30 minutes after administration and trough level just before the next dose). It is not the priority to obtain these levels before the first dose. In this case, the priority is to administer the first dose promptly.

C. Withhold antibiotic administration until the healthcare provider clarifies the prescriptions:

Delaying the administration of the new antibiotic might not be appropriate, especially if the infection is severe and the healthcare provider has indicated a change in therapy. While clarifying prescriptions is important, it should not delay the administration of the aminoglycoside unless there are concerns about adverse interactions or contraindications.

D. Schedule the initial dose of the aminoglycoside antibiotic for the following day:

Delaying the first dose until the following day is not ideal. If the client requires immediate treatment for an infection, this could cause worsening of the condition or even complications. The goal is to administer the antibiotic promptly to control the infection.

Conclusion:

B. Administer the initial dose of the aminoglycoside antibiotic as soon as possible is the most appropriate action. The nurse should follow the healthcare provider’s order and administer the aminoglycoside promptly, while closely monitoring the client for any potential adverse effects or complications.

Correct Answer D: One hour before meals and at bedtime

Explanation of the Correct Answer:

D. One hour before meals and at bedtime is correct because sucralfate (Carafate) works best when taken on an empty stomach, as it forms a protective barrier over the ulcer, preventing further irritation. The optimal timing for sucralfate is one hour before meals and at bedtime. Taking the medication at these times maximizes its effectiveness in protecting the stomach lining and promoting healing.

Why the other options are incorrect:

A. With meals and at bedtime

is incorrect because sucralfate should be taken before meals, not with meals. When taken with meals, the medication may not adhere as effectively to the ulcer, reducing its protective effect.

B. Every 6 hours around the clock

is incorrect because sucralfate should not be taken at regular intervals like this. The medication should be taken before meals and at bedtime, as this ensures the drug has adequate time to work and form a protective barrier on the ulcer.

C. One hour after meals and at bedtime

is incorrect because sucralfate should be taken before meals, not after. Taking it after meals could interfere with its ability to coat the ulcer properly, as food may already be present in the stomach.

Summary:

The optimal timing for sucralfate (Carafate) is one hour before meals and at bedtime. This schedule ensures that the medication is most effective at forming a protective coating over the ulcer, helping to promote healing. Taking it with or after meals may reduce the medication's effectiveness.

Correct answer:

A. Clarithromycin (Biaxin).

D. Omeprazole (Prilosec).

E. Metronidazole (Flagyl).

Explanation of the correct answers:

Peptic ulcer disease (PUD) caused by Helicobacter pylori (H. pylori) is often treated with a combination of antibiotics to eradicate the bacteria and medications to reduce stomach acid, promoting healing of the ulcer. The typical treatment regimen includes:

Clarithromycin (Biaxin): This is an antibiotic commonly prescribed to treat H. pylori infections. It works by inhibiting bacterial protein synthesis, effectively helping to eradicate the bacteria.

Omeprazole (Prilosec): This is a proton pump inhibitor (PPI) that decreases gastric acid production. Reducing acid helps to promote ulcer healing and enhances the efficacy of the antibiotics used to treat H. pylori.

Metronidazole (Flagyl): Another antibiotic used in combination with clarithromycin and omeprazole to treat H. pylori infections. It works by inhibiting the growth of the bacteria and is typically used in cases where the infection is resistant to other antibiotics.

Why the other options are incorrect:

B. Sulfisoxazole (Gantrisin): This is a sulfonamide antibiotic, but it is not commonly used to treat H. pylori infections or peptic ulcers. It is more often used for urinary tract infections. Sulfisoxazole is not a part of the standard treatment for H. pylori.

C. Misoprostol (Cytotec): Misoprostol is a prostaglandin analog that can be used to prevent NSAID-induced ulcers but is not typically used to treat ulcers caused by H. pylori. It is used more for preventing gastric ulcers associated with nonsteroidal anti-inflammatory drugs (NSAIDs).

F. Sucralfate (Carafate): Sucralfate is a medication that coats the ulcer and provides a protective barrier to promote healing, but it is not used to treat the underlying H. pylori infection. While it can help in ulcer healing, it does not eradicate the infection.

Summary:

The nurse should expect the healthcare provider to prescribe a combination of antibiotics (such as clarithromycin and metronidazole) and a proton pump inhibitor (such as omeprazole) for the treatment of peptic ulcer disease caused by Helicobacter pylori. These medications are essential for eradicating the bacteria and reducing gastric acid to promote healing. Other medications, like misoprostol and sucralfate, are not typically used for this purpose.

Correct answer A: Glaucoma

Explanation of the correct answer:

A. Glaucoma

Cyclobenzaprine (Flexeril) is a muscle relaxant that works centrally in the CNS. It has anticholinergic effects, which can increase intraocular pressure, making it potentially harmful to clients with glaucoma (especially narrow-angle glaucoma). In patients with glaucoma, these anticholinergic effects can worsen the condition by increasing pressure in the eye, which can lead to visual disturbances or worsening of glaucoma. Therefore, the nurse should contact the healthcare provider if the client has a history of glaucoma.

Why the other options are incorrect:

B. Emphysema

While cyclobenzaprine can cause sedation and drowsiness, it is not contraindicated for clients with emphysema. However, the nurse should monitor for any respiratory depression or exacerbation of symptoms, as muscle relaxants can sometimes make breathing more difficult in patients with severe pulmonary conditions. Nonetheless, glaucoma poses a more direct risk with this medication.

C. Hyperthyroidism

Cyclobenzaprine does not have a direct contraindication for clients with hyperthyroidism. However, it should be used with caution in patients with cardiovascular issues, as hyperthyroidism can affect the heart. While hyperthyroidism itself is not a specific concern with cyclobenzaprine, glaucoma remains a more urgent contraindication.

D. Diabetes mellitus

There is no direct contraindication between diabetes mellitus and cyclobenzaprine. However, the nurse should continue to monitor the client for any side effects that may affect glucose control (such as changes in appetite, drowsiness, or dizziness), but diabetes itself is not a reason to contact the healthcare provider about cyclobenzaprine administration.

Summary:

Glaucoma is the most concerning condition related to cyclobenzaprine due to its anticholinergic effects that can increase intraocular pressure, worsening glaucoma. Therefore, the nurse should contact the healthcare provider if the client has a history of glaucoma.

Correct answer A: Tinnitus and hearing loss.

Explanation of the correct answer:

Tinnitus (ringing in the ears) and hearing loss are classic signs of acute salicylate toxicity, which can occur after the ingestion of large amounts of aspirin or other salicylates. Salicylates, including aspirin, have ototoxic properties, meaning they can cause damage to the auditory system. These symptoms typically appear early in toxicity and are used to assess whether a client may be experiencing an overdose or toxic reaction. Tinnitus is often the first indication of toxicity and can progress to hearing loss if the toxicity is not addressed promptly.

Why the other options are incorrect:

B. Photosensitivity and nervousness:

These symptoms are generally not associated with salicylate toxicity. While certain medications or conditions may cause photosensitivity and nervousness, they are not characteristic signs of salicylate intoxication.

C. Acute gastrointestinal bleeding and anorexia:

While gastrointestinal bleeding can be a complication of chronic salicylate use (due to the irritant effect of salicylates on the gastric mucosa), acute gastrointestinal bleeding is more often associated with acute overdose. Anorexia may also occur in chronic intoxication, but these are not the hallmark symptoms of salicylate poisoning.

D. Hyperventilation and central nervous system effects:

Although hyperventilation and central nervous system effects (e.g., confusion, lethargy) are observed in chronic salicylate toxicity, tinnitus and hearing loss are more characteristic of acute salicylate poisoning.

Summary:

Tinnitus and hearing loss are hallmark signs of acute salicylate toxicity, making them the key symptoms to monitor for in cases of suspected overdose. This toxicity is caused by the ototoxic effects of salicylates on the auditory system. Chronic salicylate toxicity, on the other hand, is more associated with metabolic and neurological disturbances like hyperventilation and central nervous system effects.

Correct answer B: Drink at least 8 glasses of water a day.

Explanation of the correct answer:

Sulfamethoxazole-trimethoprim (Septra) is a sulfonamide antibiotic commonly prescribed to treat urinary tract infections (UTIs). One of the important instructions for clients taking this medication is to drink plenty of fluids, at least 8 glasses of water a day. This helps to prevent the formation of crystalluria, which is the precipitation of drug crystals in the urine that can potentially lead to kidney damage. Staying hydrated helps flush out the drug and decreases the risk of urinary tract problems associated with sulfamethoxazole-trimethoprim.

Why the other options are incorrect:

A. Ingest food prior to taking the antibiotic:

It is generally not necessary to take sulfamethoxazole-trimethoprim with food, unless it causes gastrointestinal discomfort. Taking the medication with or without food can be acceptable, but the priority is ensuring hydration, not food intake.

C. Take the medication with grapefruit juice:

Grapefruit juice can interact with several medications, particularly those metabolized by the liver's cytochrome P450 enzymes. However, there is no known significant interaction between sulfamethoxazole-trimethoprim and grapefruit juice. Still, it is generally recommended to avoid grapefruit juice unless specifically cleared by a healthcare provider due to its potential for drug interactions with other medications.

D. Avoid prolonged exposure to sunlight:

While it is true that sulfonamides can increase sensitivity to sunlight (photosensitivity), this is not the most important instruction for this medication. Hydration is a more critical concern in preventing complications from sulfamethoxazole-trimethoprim therapy.

Summary:

For clients taking sulfamethoxazole-trimethoprim, it is important to ensure adequate hydration to prevent kidney problems. Drinking at least 8 glasses of water a day helps maintain adequate urinary output and reduces the risk of crystalluria, which can lead to kidney damage.

Correct answer B: 10 to 20 mcg/mL

Explanation of the correct answer:

B. 10 to 20 mcg/mL

Phenytoin (Dilantin) is an anticonvulsant used to manage and prevent seizures. It has a narrow therapeutic index, which means that blood levels must be carefully monitored to ensure effectiveness without causing toxicity. The therapeutic serum level for phenytoin is 10 to 20 mcg/mL. Within this range, the drug is typically effective in controlling seizures while minimizing the risk of side effects. Levels below 10 mcg/mL may result in inadequate seizure control, while levels above 20 mcg/mL increase the risk for toxicity, which can cause symptoms such as nystagmus, ataxia, slurred speech, confusion, lethargy, and potentially life-threatening cardiac arrhythmias.

Why the other options are incorrect:

A. 5 to 10 mcg/mL

This range is below the therapeutic level and may be insufficient to control seizures, putting the client at risk for breakthrough seizure activity.

C. 20 to 30 mcg/mL

This range is above the therapeutic level and increases the risk for phenytoin toxicity. Levels greater than 20 mcg/mL can lead to central nervous system and cardiovascular side effects.

D. 30 to 40 mcg/mL

This range is considered toxic and poses a serious risk to the client. At this level, immediate medical intervention is necessary to prevent life-threatening complications.

Summary:

A serum phenytoin level between 10 to 20 mcg/mL is considered therapeutic and safe for most clients. Monitoring this range is essential for ensuring the medication is both effective and non-toxic.

Correct Answer A: Tinnitus

Explanation of the Correct Answer:

A. Tinnitus is correct because it is a classic early sign of salicylate (salicylic acid) toxicity. Salicylic acid, when absorbed systemically in excessive amounts—either through extensive topical use or ingestion—can lead to salicylism. Symptoms of salicylism include ringing in the ears (tinnitus), dizziness, headache, nausea, and confusion. Tinnitus often presents before more serious symptoms and serves as an important clinical indicator of potential toxicity.

Why the other options are incorrect:

B. Diarrhea is incorrect because it is not a hallmark symptom of salicylate toxicity. While gastrointestinal upset may occur with systemic salicylate ingestion, diarrhea specifically is not a reliable or common indicator of toxicity.

C. Constipation is incorrect because salicylate toxicity does not typically manifest with constipation. In fact, systemic absorption of salicylates more commonly causes nausea and vomiting rather than slowed bowel function.

D. Decreased respirations is incorrect because salicylate toxicity generally causes increased respiratory rate (hyperventilation) due to stimulation of the respiratory center in the brain, leading to respiratory alkalosis in the early stages. Decreased respirations may occur later with severe toxicity and respiratory failure, but this is a late and more critical sign, not an early or reliable indicator.

Summary:

The presence of tinnitus is the most reliable early indicator of systemic toxicity from salicylic acid. Other options like diarrhea, constipation, and decreased respirations are not characteristic early signs and may indicate other conditions or late-stage complications. Therefore, the nurse should be particularly vigilant for tinnitus in clients receiving salicylic acid therapy.